2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
To evaluate efficacy and tolerability of specific subcutaneous immunotherapy with a cocktail
of recombinant major allergens of Timothy Grass Pollen (Phleum pratense) in subjects with
rhinoconjunctivitis caused by grass pollen with/without controlled asthma.